nodes	percent_of_prediction	percent_of_DWPC	metapath
Eplerenone—NR3C2—Betamethasone—ankylosing spondylitis	0.141	0.308	CbGbCtD
Eplerenone—NR3C2—Prednisolone—ankylosing spondylitis	0.139	0.304	CbGbCtD
Eplerenone—NR3C2—Dexamethasone—ankylosing spondylitis	0.0821	0.179	CbGbCtD
Eplerenone—Medroxyprogesterone Acetate—Methylprednisolone—ankylosing spondylitis	0.0264	0.0513	CrCrCtD
Eplerenone—Hydrocortamate—Methylprednisolone—ankylosing spondylitis	0.0239	0.0463	CrCrCtD
Eplerenone—Cortisone acetate—Methylprednisolone—ankylosing spondylitis	0.0231	0.0449	CrCrCtD
Eplerenone—Hydrocortamate—Prednisone—ankylosing spondylitis	0.0218	0.0423	CrCrCtD
Eplerenone—Hydrocortamate—Prednisolone—ankylosing spondylitis	0.0213	0.0413	CrCrCtD
Eplerenone—Cortisone acetate—Prednisone—ankylosing spondylitis	0.0211	0.041	CrCrCtD
Eplerenone—Cortisone acetate—Prednisolone—ankylosing spondylitis	0.0206	0.04	CrCrCtD
Eplerenone—Fluoxymesterone—Betamethasone—ankylosing spondylitis	0.0203	0.0394	CrCrCtD
Eplerenone—Fluoxymesterone—Dexamethasone—ankylosing spondylitis	0.0203	0.0394	CrCrCtD
Eplerenone—Fludrocortisone—Methylprednisolone—ankylosing spondylitis	0.0201	0.039	CrCrCtD
Eplerenone—Fluoxymesterone—Triamcinolone—ankylosing spondylitis	0.0198	0.0385	CrCrCtD
Eplerenone—Fludrocortisone—Dexamethasone—ankylosing spondylitis	0.0198	0.0384	CrCrCtD
Eplerenone—Fludrocortisone—Betamethasone—ankylosing spondylitis	0.0198	0.0384	CrCrCtD
Eplerenone—CYP3A5—Sulfasalazine—ankylosing spondylitis	0.0194	0.0424	CbGbCtD
Eplerenone—Fludrocortisone—Triamcinolone—ankylosing spondylitis	0.0193	0.0375	CrCrCtD
Eplerenone—Fluoxymesterone—Prednisolone—ankylosing spondylitis	0.0184	0.0357	CrCrCtD
Eplerenone—Fludrocortisone—Prednisone—ankylosing spondylitis	0.0183	0.0356	CrCrCtD
Eplerenone—Fludrocortisone—Prednisolone—ankylosing spondylitis	0.0179	0.0348	CrCrCtD
Eplerenone—Progesterone—Prednisolone—ankylosing spondylitis	0.0179	0.0348	CrCrCtD
Eplerenone—Methyltestosterone—Prednisone—ankylosing spondylitis	0.0179	0.0347	CrCrCtD
Eplerenone—Methyltestosterone—Prednisolone—ankylosing spondylitis	0.0175	0.0339	CrCrCtD
Eplerenone—Hydrocortisone—Methylprednisolone—ankylosing spondylitis	0.0164	0.0318	CrCrCtD
Eplerenone—Hydrocortisone—Betamethasone—ankylosing spondylitis	0.0161	0.0313	CrCrCtD
Eplerenone—Hydrocortisone—Dexamethasone—ankylosing spondylitis	0.0161	0.0313	CrCrCtD
Eplerenone—Hydrocortisone—Triamcinolone—ankylosing spondylitis	0.0158	0.0306	CrCrCtD
Eplerenone—Testosterone—Prednisolone—ankylosing spondylitis	0.0155	0.0302	CrCrCtD
Eplerenone—Hydrocortisone—Prednisone—ankylosing spondylitis	0.015	0.029	CrCrCtD
Eplerenone—Hydrocortisone—Prednisolone—ankylosing spondylitis	0.0146	0.0283	CrCrCtD
Eplerenone—CYP3A7-CYP3A51P—Dexamethasone—ankylosing spondylitis	0.0129	0.0282	CbGbCtD
Eplerenone—CYP3A7—Dexamethasone—ankylosing spondylitis	0.0129	0.0282	CbGbCtD
Eplerenone—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.00999	0.0218	CbGbCtD
Eplerenone—CYP3A5—Dexamethasone—ankylosing spondylitis	0.00969	0.0212	CbGbCtD
Eplerenone—CYP3A4—Triamcinolone—ankylosing spondylitis	0.00757	0.0165	CbGbCtD
Eplerenone—CYP3A4—Betamethasone—ankylosing spondylitis	0.0065	0.0142	CbGbCtD
Eplerenone—CYP3A4—Prednisolone—ankylosing spondylitis	0.00641	0.014	CbGbCtD
Eplerenone—CYP3A4—Prednisone—ankylosing spondylitis	0.00605	0.0132	CbGbCtD
Eplerenone—CYP3A4—Dexamethasone—ankylosing spondylitis	0.00378	0.00825	CbGbCtD
Eplerenone—Hyperglycaemia—Dexamethasone—ankylosing spondylitis	0.000125	0.00466	CcSEcCtD
Eplerenone—Alanine aminotransferase increased—Prednisone—ankylosing spondylitis	0.000123	0.00459	CcSEcCtD
Eplerenone—Acute coronary syndrome—Dexamethasone—ankylosing spondylitis	0.000122	0.00454	CcSEcCtD
Eplerenone—Acute coronary syndrome—Betamethasone—ankylosing spondylitis	0.000122	0.00454	CcSEcCtD
Eplerenone—Pharyngitis—Triamcinolone—ankylosing spondylitis	0.000122	0.00452	CcSEcCtD
Eplerenone—Myocardial infarction—Dexamethasone—ankylosing spondylitis	0.000121	0.00451	CcSEcCtD
Eplerenone—Myocardial infarction—Betamethasone—ankylosing spondylitis	0.000121	0.00451	CcSEcCtD
Eplerenone—Neuropathy peripheral—Betamethasone—ankylosing spondylitis	0.000121	0.00451	CcSEcCtD
Eplerenone—Neuropathy peripheral—Dexamethasone—ankylosing spondylitis	0.000121	0.00451	CcSEcCtD
Eplerenone—Connective tissue disorder—Methylprednisolone—ankylosing spondylitis	0.00012	0.00447	CcSEcCtD
Eplerenone—Cardiac disorder—Methylprednisolone—ankylosing spondylitis	0.000113	0.00422	CcSEcCtD
Eplerenone—Angiopathy—Methylprednisolone—ankylosing spondylitis	0.000111	0.00413	CcSEcCtD
Eplerenone—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.00011	0.0041	CcSEcCtD
Eplerenone—Hyperglycaemia—Prednisone—ankylosing spondylitis	0.000109	0.00406	CcSEcCtD
Eplerenone—Ill-defined disorder—Prednisolone—ankylosing spondylitis	0.000108	0.004	CcSEcCtD
Eplerenone—Depression—Prednisone—ankylosing spondylitis	0.000108	0.004	CcSEcCtD
Eplerenone—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.000107	0.00398	CcSEcCtD
Eplerenone—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.000106	0.00396	CcSEcCtD
Eplerenone—Acute coronary syndrome—Prednisone—ankylosing spondylitis	0.000106	0.00395	CcSEcCtD
Eplerenone—Angioedema—Prednisolone—ankylosing spondylitis	0.000106	0.00394	CcSEcCtD
Eplerenone—Neuropathy peripheral—Prednisone—ankylosing spondylitis	0.000106	0.00393	CcSEcCtD
Eplerenone—Myocardial infarction—Prednisone—ankylosing spondylitis	0.000106	0.00393	CcSEcCtD
Eplerenone—Malaise—Prednisolone—ankylosing spondylitis	0.000105	0.00389	CcSEcCtD
Eplerenone—Syncope—Prednisolone—ankylosing spondylitis	0.000104	0.00387	CcSEcCtD
Eplerenone—Back pain—Triamcinolone—ankylosing spondylitis	0.000103	0.00384	CcSEcCtD
Eplerenone—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.000102	0.00379	CcSEcCtD
Eplerenone—Angiopathy—Dexamethasone—ankylosing spondylitis	0.000101	0.00375	CcSEcCtD
Eplerenone—Angiopathy—Betamethasone—ankylosing spondylitis	0.000101	0.00375	CcSEcCtD
Eplerenone—Eosinophilia—Methotrexate—ankylosing spondylitis	0.0001	0.00372	CcSEcCtD
Eplerenone—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	9.89e-05	0.00368	CcSEcCtD
Eplerenone—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	9.87e-05	0.00367	CcSEcCtD
Eplerenone—Discomfort—Prednisolone—ankylosing spondylitis	9.75e-05	0.00363	CcSEcCtD
Eplerenone—Angioedema—Triamcinolone—ankylosing spondylitis	9.74e-05	0.00362	CcSEcCtD
Eplerenone—Angioedema—Methylprednisolone—ankylosing spondylitis	9.72e-05	0.00362	CcSEcCtD
Eplerenone—Malaise—Triamcinolone—ankylosing spondylitis	9.62e-05	0.00358	CcSEcCtD
Eplerenone—Malaise—Methylprednisolone—ankylosing spondylitis	9.59e-05	0.00357	CcSEcCtD
Eplerenone—Syncope—Triamcinolone—ankylosing spondylitis	9.56e-05	0.00356	CcSEcCtD
Eplerenone—Syncope—Methylprednisolone—ankylosing spondylitis	9.54e-05	0.00355	CcSEcCtD
Eplerenone—Connective tissue disorder—Prednisone—ankylosing spondylitis	9.51e-05	0.00354	CcSEcCtD
Eplerenone—Upper respiratory tract infection—Methotrexate—ankylosing spondylitis	9.39e-05	0.00349	CcSEcCtD
Eplerenone—Loss of consciousness—Triamcinolone—ankylosing spondylitis	9.37e-05	0.00349	CcSEcCtD
Eplerenone—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	9.35e-05	0.00348	CcSEcCtD
Eplerenone—Shock—Prednisolone—ankylosing spondylitis	9.31e-05	0.00346	CcSEcCtD
Eplerenone—Cough—Triamcinolone—ankylosing spondylitis	9.3e-05	0.00346	CcSEcCtD
Eplerenone—Hyperhidrosis—Prednisolone—ankylosing spondylitis	9.15e-05	0.0034	CcSEcCtD
Eplerenone—Myalgia—Triamcinolone—ankylosing spondylitis	9.08e-05	0.00338	CcSEcCtD
Eplerenone—Pneumonia—Methotrexate—ankylosing spondylitis	9.06e-05	0.00337	CcSEcCtD
Eplerenone—Arthralgia—Methylprednisolone—ankylosing spondylitis	9.06e-05	0.00337	CcSEcCtD
Eplerenone—Myalgia—Methylprednisolone—ankylosing spondylitis	9.06e-05	0.00337	CcSEcCtD
Eplerenone—Infestation NOS—Methotrexate—ankylosing spondylitis	9.01e-05	0.00335	CcSEcCtD
Eplerenone—Infestation—Methotrexate—ankylosing spondylitis	9.01e-05	0.00335	CcSEcCtD
Eplerenone—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	8.99e-05	0.00335	CcSEcCtD
Eplerenone—Depression—Methotrexate—ankylosing spondylitis	8.98e-05	0.00334	CcSEcCtD
Eplerenone—Flushing—Prednisone—ankylosing spondylitis	8.98e-05	0.00334	CcSEcCtD
Eplerenone—Ill-defined disorder—Betamethasone—ankylosing spondylitis	8.98e-05	0.00334	CcSEcCtD
Eplerenone—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	8.98e-05	0.00334	CcSEcCtD
Eplerenone—Discomfort—Triamcinolone—ankylosing spondylitis	8.97e-05	0.00334	CcSEcCtD
Eplerenone—Discomfort—Methylprednisolone—ankylosing spondylitis	8.95e-05	0.00333	CcSEcCtD
Eplerenone—Renal failure—Methotrexate—ankylosing spondylitis	8.86e-05	0.0033	CcSEcCtD
Eplerenone—Angioedema—Betamethasone—ankylosing spondylitis	8.84e-05	0.00329	CcSEcCtD
Eplerenone—Angioedema—Dexamethasone—ankylosing spondylitis	8.84e-05	0.00329	CcSEcCtD
Eplerenone—Angiopathy—Prednisone—ankylosing spondylitis	8.78e-05	0.00327	CcSEcCtD
Eplerenone—Malaise—Dexamethasone—ankylosing spondylitis	8.72e-05	0.00325	CcSEcCtD
Eplerenone—Malaise—Betamethasone—ankylosing spondylitis	8.72e-05	0.00325	CcSEcCtD
Eplerenone—Syncope—Betamethasone—ankylosing spondylitis	8.68e-05	0.00323	CcSEcCtD
Eplerenone—Syncope—Dexamethasone—ankylosing spondylitis	8.68e-05	0.00323	CcSEcCtD
Eplerenone—Infection—Triamcinolone—ankylosing spondylitis	8.65e-05	0.00322	CcSEcCtD
Eplerenone—Infection—Methylprednisolone—ankylosing spondylitis	8.63e-05	0.00321	CcSEcCtD
Eplerenone—Haematuria—Methotrexate—ankylosing spondylitis	8.59e-05	0.0032	CcSEcCtD
Eplerenone—Shock—Triamcinolone—ankylosing spondylitis	8.56e-05	0.00319	CcSEcCtD
Eplerenone—Insomnia—Prednisolone—ankylosing spondylitis	8.56e-05	0.00318	CcSEcCtD
Eplerenone—Shock—Methylprednisolone—ankylosing spondylitis	8.54e-05	0.00318	CcSEcCtD
Eplerenone—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	8.52e-05	0.00317	CcSEcCtD
Eplerenone—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	8.51e-05	0.00317	CcSEcCtD
Eplerenone—Loss of consciousness—Betamethasone—ankylosing spondylitis	8.5e-05	0.00316	CcSEcCtD
Eplerenone—Loss of consciousness—Dexamethasone—ankylosing spondylitis	8.5e-05	0.00316	CcSEcCtD
Eplerenone—Mental disorder—Prednisone—ankylosing spondylitis	8.48e-05	0.00315	CcSEcCtD
Eplerenone—Skin disorder—Methylprednisolone—ankylosing spondylitis	8.43e-05	0.00314	CcSEcCtD
Eplerenone—Malnutrition—Prednisone—ankylosing spondylitis	8.43e-05	0.00313	CcSEcCtD
Eplerenone—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	8.41e-05	0.00313	CcSEcCtD
Eplerenone—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	8.39e-05	0.00312	CcSEcCtD
Eplerenone—Myalgia—Dexamethasone—ankylosing spondylitis	8.24e-05	0.00306	CcSEcCtD
Eplerenone—Myalgia—Betamethasone—ankylosing spondylitis	8.24e-05	0.00306	CcSEcCtD
Eplerenone—Discomfort—Betamethasone—ankylosing spondylitis	8.14e-05	0.00303	CcSEcCtD
Eplerenone—Discomfort—Dexamethasone—ankylosing spondylitis	8.14e-05	0.00303	CcSEcCtD
Eplerenone—Hypotension—Methylprednisolone—ankylosing spondylitis	8.11e-05	0.00302	CcSEcCtD
Eplerenone—Pain—Prednisolone—ankylosing spondylitis	8.09e-05	0.00301	CcSEcCtD
Eplerenone—Pharyngitis—Methotrexate—ankylosing spondylitis	8.03e-05	0.00299	CcSEcCtD
Eplerenone—Urinary tract disorder—Methotrexate—ankylosing spondylitis	7.99e-05	0.00297	CcSEcCtD
Eplerenone—Urethral disorder—Methotrexate—ankylosing spondylitis	7.93e-05	0.00295	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	7.93e-05	0.00295	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	7.91e-05	0.00294	CcSEcCtD
Eplerenone—Insomnia—Triamcinolone—ankylosing spondylitis	7.87e-05	0.00293	CcSEcCtD
Eplerenone—Insomnia—Methylprednisolone—ankylosing spondylitis	7.85e-05	0.00292	CcSEcCtD
Eplerenone—Infection—Betamethasone—ankylosing spondylitis	7.84e-05	0.00292	CcSEcCtD
Eplerenone—Infection—Dexamethasone—ankylosing spondylitis	7.84e-05	0.00292	CcSEcCtD
Eplerenone—Ill-defined disorder—Prednisone—ankylosing spondylitis	7.82e-05	0.00291	CcSEcCtD
Eplerenone—Feeling abnormal—Prednisolone—ankylosing spondylitis	7.8e-05	0.0029	CcSEcCtD
Eplerenone—Anaemia—Prednisone—ankylosing spondylitis	7.79e-05	0.0029	CcSEcCtD
Eplerenone—Shock—Dexamethasone—ankylosing spondylitis	7.77e-05	0.00289	CcSEcCtD
Eplerenone—Shock—Betamethasone—ankylosing spondylitis	7.77e-05	0.00289	CcSEcCtD
Eplerenone—Dyspnoea—Triamcinolone—ankylosing spondylitis	7.76e-05	0.00289	CcSEcCtD
Eplerenone—Nervous system disorder—Dexamethasone—ankylosing spondylitis	7.74e-05	0.00288	CcSEcCtD
Eplerenone—Nervous system disorder—Betamethasone—ankylosing spondylitis	7.74e-05	0.00288	CcSEcCtD
Eplerenone—Angioedema—Prednisone—ankylosing spondylitis	7.7e-05	0.00286	CcSEcCtD
Eplerenone—Dyspepsia—Triamcinolone—ankylosing spondylitis	7.66e-05	0.00285	CcSEcCtD
Eplerenone—Dyspepsia—Methylprednisolone—ankylosing spondylitis	7.64e-05	0.00284	CcSEcCtD
Eplerenone—Hyperhidrosis—Betamethasone—ankylosing spondylitis	7.63e-05	0.00284	CcSEcCtD
Eplerenone—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	7.63e-05	0.00284	CcSEcCtD
Eplerenone—Malaise—Prednisone—ankylosing spondylitis	7.6e-05	0.00283	CcSEcCtD
Eplerenone—Syncope—Prednisone—ankylosing spondylitis	7.56e-05	0.00281	CcSEcCtD
Eplerenone—Tinnitus—Methotrexate—ankylosing spondylitis	7.54e-05	0.00281	CcSEcCtD
Eplerenone—Cardiac disorder—Methotrexate—ankylosing spondylitis	7.51e-05	0.00279	CcSEcCtD
Eplerenone—Fatigue—Triamcinolone—ankylosing spondylitis	7.5e-05	0.00279	CcSEcCtD
Eplerenone—Fatigue—Methylprednisolone—ankylosing spondylitis	7.49e-05	0.00278	CcSEcCtD
Eplerenone—Pain—Triamcinolone—ankylosing spondylitis	7.44e-05	0.00277	CcSEcCtD
Eplerenone—Loss of consciousness—Prednisone—ankylosing spondylitis	7.41e-05	0.00275	CcSEcCtD
Eplerenone—Hypotension—Dexamethasone—ankylosing spondylitis	7.38e-05	0.00274	CcSEcCtD
Eplerenone—Hypotension—Betamethasone—ankylosing spondylitis	7.38e-05	0.00274	CcSEcCtD
Eplerenone—Angiopathy—Methotrexate—ankylosing spondylitis	7.34e-05	0.00273	CcSEcCtD
Eplerenone—Mediastinal disorder—Methotrexate—ankylosing spondylitis	7.29e-05	0.00271	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	7.19e-05	0.00268	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	7.19e-05	0.00268	CcSEcCtD
Eplerenone—Myalgia—Prednisone—ankylosing spondylitis	7.17e-05	0.00267	CcSEcCtD
Eplerenone—Arthralgia—Prednisone—ankylosing spondylitis	7.17e-05	0.00267	CcSEcCtD
Eplerenone—Feeling abnormal—Triamcinolone—ankylosing spondylitis	7.17e-05	0.00267	CcSEcCtD
Eplerenone—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	7.15e-05	0.00266	CcSEcCtD
Eplerenone—Insomnia—Dexamethasone—ankylosing spondylitis	7.14e-05	0.00266	CcSEcCtD
Eplerenone—Insomnia—Betamethasone—ankylosing spondylitis	7.14e-05	0.00266	CcSEcCtD
Eplerenone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	7.12e-05	0.00265	CcSEcCtD
Eplerenone—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	7.1e-05	0.00264	CcSEcCtD
Eplerenone—Discomfort—Prednisone—ankylosing spondylitis	7.09e-05	0.00264	CcSEcCtD
Eplerenone—Mental disorder—Methotrexate—ankylosing spondylitis	7.09e-05	0.00264	CcSEcCtD
Eplerenone—Malnutrition—Methotrexate—ankylosing spondylitis	7.04e-05	0.00262	CcSEcCtD
Eplerenone—Dyspepsia—Dexamethasone—ankylosing spondylitis	6.95e-05	0.00259	CcSEcCtD
Eplerenone—Dyspepsia—Betamethasone—ankylosing spondylitis	6.95e-05	0.00259	CcSEcCtD
Eplerenone—Body temperature increased—Triamcinolone—ankylosing spondylitis	6.88e-05	0.00256	CcSEcCtD
Eplerenone—Abdominal pain—Methylprednisolone—ankylosing spondylitis	6.86e-05	0.00255	CcSEcCtD
Eplerenone—Infection—Prednisone—ankylosing spondylitis	6.83e-05	0.00254	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	6.82e-05	0.00254	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	6.82e-05	0.00254	CcSEcCtD
Eplerenone—Back pain—Methotrexate—ankylosing spondylitis	6.81e-05	0.00253	CcSEcCtD
Eplerenone—Fatigue—Dexamethasone—ankylosing spondylitis	6.81e-05	0.00253	CcSEcCtD
Eplerenone—Fatigue—Betamethasone—ankylosing spondylitis	6.81e-05	0.00253	CcSEcCtD
Eplerenone—Shock—Prednisone—ankylosing spondylitis	6.77e-05	0.00252	CcSEcCtD
Eplerenone—Pain—Dexamethasone—ankylosing spondylitis	6.75e-05	0.00251	CcSEcCtD
Eplerenone—Pain—Betamethasone—ankylosing spondylitis	6.75e-05	0.00251	CcSEcCtD
Eplerenone—Nervous system disorder—Prednisone—ankylosing spondylitis	6.74e-05	0.00251	CcSEcCtD
Eplerenone—Skin disorder—Prednisone—ankylosing spondylitis	6.68e-05	0.00248	CcSEcCtD
Eplerenone—Hyperhidrosis—Prednisone—ankylosing spondylitis	6.65e-05	0.00247	CcSEcCtD
Eplerenone—Ill-defined disorder—Methotrexate—ankylosing spondylitis	6.53e-05	0.00243	CcSEcCtD
Eplerenone—Anaemia—Methotrexate—ankylosing spondylitis	6.51e-05	0.00242	CcSEcCtD
Eplerenone—Feeling abnormal—Dexamethasone—ankylosing spondylitis	6.51e-05	0.00242	CcSEcCtD
Eplerenone—Feeling abnormal—Betamethasone—ankylosing spondylitis	6.51e-05	0.00242	CcSEcCtD
Eplerenone—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	6.46e-05	0.0024	CcSEcCtD
Eplerenone—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	6.46e-05	0.0024	CcSEcCtD
Eplerenone—Malaise—Methotrexate—ankylosing spondylitis	6.35e-05	0.00236	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	6.26e-05	0.00233	CcSEcCtD
Eplerenone—Dizziness—Prednisolone—ankylosing spondylitis	6.26e-05	0.00233	CcSEcCtD
Eplerenone—Asthenia—Triamcinolone—ankylosing spondylitis	6.24e-05	0.00232	CcSEcCtD
Eplerenone—Body temperature increased—Betamethasone—ankylosing spondylitis	6.24e-05	0.00232	CcSEcCtD
Eplerenone—Abdominal pain—Dexamethasone—ankylosing spondylitis	6.24e-05	0.00232	CcSEcCtD
Eplerenone—Body temperature increased—Dexamethasone—ankylosing spondylitis	6.24e-05	0.00232	CcSEcCtD
Eplerenone—Abdominal pain—Betamethasone—ankylosing spondylitis	6.24e-05	0.00232	CcSEcCtD
Eplerenone—Asthenia—Methylprednisolone—ankylosing spondylitis	6.23e-05	0.00232	CcSEcCtD
Eplerenone—Insomnia—Prednisone—ankylosing spondylitis	6.22e-05	0.00231	CcSEcCtD
Eplerenone—Pruritus—Triamcinolone—ankylosing spondylitis	6.16e-05	0.00229	CcSEcCtD
Eplerenone—Cough—Methotrexate—ankylosing spondylitis	6.14e-05	0.00229	CcSEcCtD
Eplerenone—Pruritus—Methylprednisolone—ankylosing spondylitis	6.14e-05	0.00229	CcSEcCtD
Eplerenone—Dyspepsia—Prednisone—ankylosing spondylitis	6.05e-05	0.00225	CcSEcCtD
Eplerenone—Myalgia—Methotrexate—ankylosing spondylitis	5.99e-05	0.00223	CcSEcCtD
Eplerenone—Arthralgia—Methotrexate—ankylosing spondylitis	5.99e-05	0.00223	CcSEcCtD
Eplerenone—Chest pain—Methotrexate—ankylosing spondylitis	5.99e-05	0.00223	CcSEcCtD
Eplerenone—Rash—Prednisolone—ankylosing spondylitis	5.97e-05	0.00222	CcSEcCtD
Eplerenone—Dermatitis—Prednisolone—ankylosing spondylitis	5.96e-05	0.00222	CcSEcCtD
Eplerenone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	5.95e-05	0.00221	CcSEcCtD
Eplerenone—Diarrhoea—Methylprednisolone—ankylosing spondylitis	5.94e-05	0.00221	CcSEcCtD
Eplerenone—Fatigue—Prednisone—ankylosing spondylitis	5.93e-05	0.00221	CcSEcCtD
Eplerenone—Headache—Prednisolone—ankylosing spondylitis	5.93e-05	0.00221	CcSEcCtD
Eplerenone—Discomfort—Methotrexate—ankylosing spondylitis	5.92e-05	0.0022	CcSEcCtD
Eplerenone—Constipation—Prednisone—ankylosing spondylitis	5.88e-05	0.00219	CcSEcCtD
Eplerenone—Dizziness—Triamcinolone—ankylosing spondylitis	5.75e-05	0.00214	CcSEcCtD
Eplerenone—Dizziness—Methylprednisolone—ankylosing spondylitis	5.74e-05	0.00214	CcSEcCtD
Eplerenone—Infection—Methotrexate—ankylosing spondylitis	5.71e-05	0.00212	CcSEcCtD
Eplerenone—Feeling abnormal—Prednisone—ankylosing spondylitis	5.67e-05	0.00211	CcSEcCtD
Eplerenone—Asthenia—Dexamethasone—ankylosing spondylitis	5.66e-05	0.00211	CcSEcCtD
Eplerenone—Asthenia—Betamethasone—ankylosing spondylitis	5.66e-05	0.00211	CcSEcCtD
Eplerenone—Nervous system disorder—Methotrexate—ankylosing spondylitis	5.64e-05	0.0021	CcSEcCtD
Eplerenone—Gastrointestinal pain—Prednisone—ankylosing spondylitis	5.62e-05	0.00209	CcSEcCtD
Eplerenone—Nausea—Prednisolone—ankylosing spondylitis	5.62e-05	0.00209	CcSEcCtD
Eplerenone—Pruritus—Dexamethasone—ankylosing spondylitis	5.59e-05	0.00208	CcSEcCtD
Eplerenone—Pruritus—Betamethasone—ankylosing spondylitis	5.59e-05	0.00208	CcSEcCtD
Eplerenone—Skin disorder—Methotrexate—ankylosing spondylitis	5.58e-05	0.00208	CcSEcCtD
Eplerenone—Hyperhidrosis—Methotrexate—ankylosing spondylitis	5.56e-05	0.00207	CcSEcCtD
Eplerenone—Vomiting—Triamcinolone—ankylosing spondylitis	5.53e-05	0.00206	CcSEcCtD
Eplerenone—Vomiting—Methylprednisolone—ankylosing spondylitis	5.52e-05	0.00205	CcSEcCtD
Eplerenone—Rash—Triamcinolone—ankylosing spondylitis	5.49e-05	0.00204	CcSEcCtD
Eplerenone—Dermatitis—Triamcinolone—ankylosing spondylitis	5.48e-05	0.00204	CcSEcCtD
Eplerenone—Rash—Methylprednisolone—ankylosing spondylitis	5.47e-05	0.00204	CcSEcCtD
Eplerenone—Dermatitis—Methylprednisolone—ankylosing spondylitis	5.47e-05	0.00203	CcSEcCtD
Eplerenone—Headache—Triamcinolone—ankylosing spondylitis	5.45e-05	0.00203	CcSEcCtD
Eplerenone—Headache—Methylprednisolone—ankylosing spondylitis	5.44e-05	0.00202	CcSEcCtD
Eplerenone—Abdominal pain—Prednisone—ankylosing spondylitis	5.44e-05	0.00202	CcSEcCtD
Eplerenone—Body temperature increased—Prednisone—ankylosing spondylitis	5.44e-05	0.00202	CcSEcCtD
Eplerenone—Diarrhoea—Betamethasone—ankylosing spondylitis	5.4e-05	0.00201	CcSEcCtD
Eplerenone—Diarrhoea—Dexamethasone—ankylosing spondylitis	5.4e-05	0.00201	CcSEcCtD
Eplerenone—Hypotension—Methotrexate—ankylosing spondylitis	5.37e-05	0.002	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	5.24e-05	0.00195	CcSEcCtD
Eplerenone—Dizziness—Dexamethasone—ankylosing spondylitis	5.22e-05	0.00194	CcSEcCtD
Eplerenone—Dizziness—Betamethasone—ankylosing spondylitis	5.22e-05	0.00194	CcSEcCtD
Eplerenone—Insomnia—Methotrexate—ankylosing spondylitis	5.2e-05	0.00193	CcSEcCtD
Eplerenone—Nausea—Triamcinolone—ankylosing spondylitis	5.17e-05	0.00192	CcSEcCtD
Eplerenone—Nausea—Methylprednisolone—ankylosing spondylitis	5.16e-05	0.00192	CcSEcCtD
Eplerenone—Dyspnoea—Methotrexate—ankylosing spondylitis	5.12e-05	0.00191	CcSEcCtD
Eplerenone—Dyspepsia—Methotrexate—ankylosing spondylitis	5.06e-05	0.00188	CcSEcCtD
Eplerenone—Vomiting—Dexamethasone—ankylosing spondylitis	5.02e-05	0.00187	CcSEcCtD
Eplerenone—Vomiting—Betamethasone—ankylosing spondylitis	5.02e-05	0.00187	CcSEcCtD
Eplerenone—Rash—Dexamethasone—ankylosing spondylitis	4.98e-05	0.00185	CcSEcCtD
Eplerenone—Rash—Betamethasone—ankylosing spondylitis	4.98e-05	0.00185	CcSEcCtD
Eplerenone—Dermatitis—Dexamethasone—ankylosing spondylitis	4.97e-05	0.00185	CcSEcCtD
Eplerenone—Dermatitis—Betamethasone—ankylosing spondylitis	4.97e-05	0.00185	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	4.96e-05	0.00185	CcSEcCtD
Eplerenone—Fatigue—Methotrexate—ankylosing spondylitis	4.95e-05	0.00184	CcSEcCtD
Eplerenone—Headache—Betamethasone—ankylosing spondylitis	4.95e-05	0.00184	CcSEcCtD
Eplerenone—Headache—Dexamethasone—ankylosing spondylitis	4.95e-05	0.00184	CcSEcCtD
Eplerenone—Asthenia—Prednisone—ankylosing spondylitis	4.93e-05	0.00184	CcSEcCtD
Eplerenone—Pain—Methotrexate—ankylosing spondylitis	4.91e-05	0.00183	CcSEcCtD
Eplerenone—Pruritus—Prednisone—ankylosing spondylitis	4.86e-05	0.00181	CcSEcCtD
Eplerenone—Feeling abnormal—Methotrexate—ankylosing spondylitis	4.74e-05	0.00176	CcSEcCtD
Eplerenone—Diarrhoea—Prednisone—ankylosing spondylitis	4.7e-05	0.00175	CcSEcCtD
Eplerenone—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	4.7e-05	0.00175	CcSEcCtD
Eplerenone—Nausea—Betamethasone—ankylosing spondylitis	4.69e-05	0.00174	CcSEcCtD
Eplerenone—Nausea—Dexamethasone—ankylosing spondylitis	4.69e-05	0.00174	CcSEcCtD
Eplerenone—Dizziness—Prednisone—ankylosing spondylitis	4.55e-05	0.00169	CcSEcCtD
Eplerenone—Abdominal pain—Methotrexate—ankylosing spondylitis	4.54e-05	0.00169	CcSEcCtD
Eplerenone—Body temperature increased—Methotrexate—ankylosing spondylitis	4.54e-05	0.00169	CcSEcCtD
Eplerenone—Vomiting—Prednisone—ankylosing spondylitis	4.37e-05	0.00163	CcSEcCtD
Eplerenone—Rash—Prednisone—ankylosing spondylitis	4.34e-05	0.00161	CcSEcCtD
Eplerenone—Dermatitis—Prednisone—ankylosing spondylitis	4.33e-05	0.00161	CcSEcCtD
Eplerenone—Headache—Prednisone—ankylosing spondylitis	4.31e-05	0.0016	CcSEcCtD
Eplerenone—Asthenia—Methotrexate—ankylosing spondylitis	4.12e-05	0.00153	CcSEcCtD
Eplerenone—Nausea—Prednisone—ankylosing spondylitis	4.08e-05	0.00152	CcSEcCtD
Eplerenone—Pruritus—Methotrexate—ankylosing spondylitis	4.07e-05	0.00151	CcSEcCtD
Eplerenone—Diarrhoea—Methotrexate—ankylosing spondylitis	3.93e-05	0.00146	CcSEcCtD
Eplerenone—Dizziness—Methotrexate—ankylosing spondylitis	3.8e-05	0.00141	CcSEcCtD
Eplerenone—Vomiting—Methotrexate—ankylosing spondylitis	3.65e-05	0.00136	CcSEcCtD
Eplerenone—Rash—Methotrexate—ankylosing spondylitis	3.62e-05	0.00135	CcSEcCtD
Eplerenone—Dermatitis—Methotrexate—ankylosing spondylitis	3.62e-05	0.00135	CcSEcCtD
Eplerenone—Headache—Methotrexate—ankylosing spondylitis	3.6e-05	0.00134	CcSEcCtD
Eplerenone—Nausea—Methotrexate—ankylosing spondylitis	3.41e-05	0.00127	CcSEcCtD
